CRVS Corvus Pharmaceuticals, Inc.

Fundamentals / CIK 0001626971 / USD

Corvus Pharmaceuticals, Inc. reported $223.9M in total assets and a net loss of $64.31M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CRVS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$58.24MFY 2016 Net Income: -$36.38M2016FY 2017 Net Income: -$55.66M2017FY 2018 Net Income: -$46.94M2018FY 2019 Net Income: -$46.67M2019FY 2020 Net Income: -$6.00M2020FY 2021 Net Income: -$43.24M2021FY 2022 Net Income: -$41.31M2022FY 2023 Net Income: -$27.03M2023FY 2024 Net Income: -$62.29M2024FY 2025 Net Income: -$15.28M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $33.72M $19.39M $16.53M $24.47M $29.11M $31.83M $37.98M $38.59M $46.30M $29.36M
Total Operating Expenses $42.97M $27.55M $23.41M $32.56M $38.63M $43.76M $48.85M $49.22M $56.52M $36.98M
Operating Income -$42.97M -$27.55M -$23.41M -$32.56M -$38.63M -$43.76M -$48.85M -$49.22M -$56.52M -$36.98M
EBITDA -$42.87M -$27.46M -$23.26M -$32.20M -$38.17M -$43.13M -$48.11M -$48.38M -$55.68M -$36.38M
Income Before Tax -$13.32M -$59.10M -$21.75M -$41.31M -$43.24M -$6.00M -$46.67M -$46.94M -$55.66M -$36.38M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$15.28M -$62.29M -$27.03M -$41.31M -$43.24M -$6.00M -$46.67M -$46.94M -$55.66M -$36.38M
Basic EPS -$0.19 -$1.02 -$0.56 -$0.89 -$1.03 -$0.20 -$1.59 -$1.71 -$2.72 -$2.36
Diluted EPS -$0.53 -$1.02 -$0.56 -$0.89 -$1.03 -$0.20 -$1.59 -$1.71 -$2.72 -$2.36
Basic Shares Outstanding 79.0M 61.0M 48.0M 46.6M 41.9M 29.5M 29.3M 27.5M 20.5M 15.4M
Diluted Shares Outstanding 79.7M 61.0M 48.0M 46.6M 41.9M 29.5M 29.3M 27.5M 20.5M 15.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $17.78M $15.96M $11.18M $9.94M $8.45M $7.87M $7.45M $5.97M
Total Operating Expenses $21.36M $19.30M $14.88M $12.22M $10.57M $10.26M $9.92M $8.11M
Operating Income -$21.36M -$19.30M -$14.88M -$12.22M -$10.57M -$10.26M -$9.92M -$8.11M
EBITDA -$21.27M -$19.26M -$14.85M -$12.19M -$10.54M -$10.23M -$9.90M -$8.09M
Income Before Tax -$19.45M -$17.25M -$13.09M -$11.61M -$9.83M -$7.61M $15.73M -$9.94M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$20.34M -$17.96M -$13.69M -$12.32M -$10.16M -$8.00M $15.19M -$12.11M
Basic EPS -$0.22 -$0.19 -$0.15 -- -$0.12 -$0.10 $0.21 --
Diluted EPS -$0.22 -$0.19 -$0.15 -- -$0.12 -$0.10 -$0.13 --
Basic Shares Outstanding 92.5M 92.4M 90.0M -- 82.8M 77.8M 72.1M --
Diluted Shares Outstanding 92.5M 92.4M 90.0M -- 82.8M 77.8M 75.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $4.58M $8.74M $12.62M $13.16M $63.46M $16.45M $5.15M $39.20M $45.11M $5.05M
Short-Term Investments $52.17M $43.22M -- -- -- -- -- -- -- --
Cash & Short-Term Investments $56.80M $52.00M $27.10M $42.30M $69.50M $44.30M $78.00M $114.6M $90.10M $134.9M
Accounts Receivable, Net $37K $75K $26K $588K -- -- -- -- -- --
Other Current Assets $353K $548K $220K $102K $128K $406K $486K $265K $412K $772K
Total Current Assets $58.21M $54.41M $27.96M $43.66M $71.31M $45.34M $79.34M $115.6M $91.23M $136.0M
Property, Plant & Equipment, Net $220K $151K $236K $353K $451K $906K $1.46M $2.18M $2.67M $3.25M
Other Non-Current Assets $855K $632K $89K $129K $236K $414K $513K $463K $869K $869K
Total Non-Current Assets $12.90M $14.50M $17.60M $24.58M $38.14M $40.19M $4.30M $2.64M $3.54M $4.12M
Total Assets $71.12M $68.91M $45.55M $68.24M $109.5M $85.53M $83.65M $118.2M $94.78M $140.2M
Accounts Payable $2.49M $2.58M $1.52M $1.98M $1.56M $3.47M $2.45M $2.00M $3.45M $1.90M
Total Current Liabilities $9.38M $35.40M $6.87M $10.75M $9.69M $12.15M $10.22M $7.03M $8.97M $5.94M
Other Non-Current Liabilities -- -- -- -- -- -- -- $869K $971K $1.41M
Total Non-Current Liabilities $534K $937K $0 $1.37M $2.60M $1.23M $2.31M $869K $971K $1.41M
Total Liabilities $9.91M $36.34M $6.87M $12.12M $12.29M $13.38M $12.54M $7.90M $9.94M $7.35M
Total Debt (incl. Leases) $937K $1.12M $1.37M $2.60M $3.65M $2.31M $3.19M -- -- --
Common Stock $7.0K $7.0K $5.0K $5.0K $5.0K $3.0K $3.0K $3.0K $2.0K $2.0K
Retained Earnings -$412.3M -$397.0M -$334.7M -$307.7M -$266.4M -$223.1M -$217.1M -$170.5M -$123.5M -$67.87M
Accumulated Other Comp. Income -$896K -$1.29M -$967K -$563K $1.87M $4.0K $29K -$34K -$41K -$39K
Total Stockholders' Equity $61.20M $32.57M $38.68M $56.12M $97.16M $72.15M $71.11M $110.3M $84.83M $132.8M
Total Equity $61.20M $32.57M $38.68M $56.12M $97.16M $72.15M $71.11M $110.3M $84.83M $132.8M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $15.01M $18.91M $40.10M $4.58M $2.87M $14.69M $5.00M $8.74M
Short-Term Investments $187.9M $196.3M $196.6M $52.17M -- -- -- $43.22M
Cash & Short-Term Investments $202.9M $215.2M $236.7M $56.80M $65.70M $74.40M $44.20M $52.00M
Accounts Receivable, Net $5.0K $6.0K $43K $37K $32K $86K $79K $75K
Other Current Assets $317K $575K $367K $353K $509K $569K $458K $548K
Total Current Assets $206.3M $221.0M $239.9M $58.21M $66.94M $75.78M $45.49M $54.41M
Property, Plant & Equipment, Net $801K $830K $282K $220K $221K $249K $165K $151K
Other Non-Current Assets $1.70M $1.71M $1.72M $855K $852K $626K $629K $632K
Total Non-Current Assets $17.53M $18.31M $13.25M $12.90M $13.53M $13.68M $13.95M $14.50M
Total Assets $223.9M $239.3M $253.2M $71.12M $80.47M $89.46M $59.44M $68.91M
Accounts Payable $5.65M $4.05M $4.70M $2.49M $1.97M $3.14M $1.31M $2.58M
Total Current Liabilities $15.42M $13.67M $12.11M $9.38M $8.07M $8.51M $9.28M $35.40M
Total Non-Current Liabilities $139K $274K $406K $534K $632K $728K $834K $937K
Total Liabilities $15.56M $13.95M $12.52M $9.91M $8.71M $9.23M $10.11M $36.34M
Total Debt (incl. Leases) $632K $728K $834K $937K $1.01M $1.08M $1.15M $1.12M
Common Stock $8.0K $8.0K $8.0K $7.0K $7.0K $7.0K $7.0K $7.0K
Retained Earnings -$464.3M -$443.9M -$426.0M -$412.3M -$400.0M -$389.8M -$381.8M -$397.0M
Accumulated Other Comp. Income -$1.59M -$1.29M -$1.13M -$896K -$1.06M -$1.15M -$1.25M -$1.29M
Total Stockholders' Equity $208.3M $225.3M $240.7M $61.20M $71.77M $80.23M $49.33M $32.57M
Total Equity $208.3M $225.3M $240.7M $61.20M $71.77M $80.23M $49.33M $32.57M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$15.28M -$62.29M -$27.03M -$41.31M -$43.24M -$6.00M -$46.67M -$46.94M -$55.66M -$36.38M
Depreciation & Amortization $105K $85K $151K $367K $460K $632K $743K $847K $842K $594K
Stock-Based Compensation $5.33M $3.00M $2.15M $2.69M $4.23M $5.75M $7.35M $7.13M $6.23M $3.83M
Change in Payables -$91K $1.06M -$451K $411K -$1.90M $1.02M $450K -$1.46M $1.55M $518K
Operating Cash Flow -$32.80M -$25.42M -$23.93M -$27.02M -$36.72M -$34.78M -$37.32M -$40.99M -$46.21M -$27.86M
Capital Expenditure -$174K -- -$34K -$269K -$5.0K -$76K -$25K -$355K -$266K -$2.20M
Free Cash Flow -$32.97M -- -$23.97M -$27.29M -$36.72M -$34.85M -$37.35M -$41.34M -$46.48M -$30.06M
Purchases of Investments -$91.75M -$70.12M -$47.05M -$66.19M -$9.36M -$42.54M -$138.6M -$161.9M -$88.31M -$258.3M
Sales & Maturities of Investments -- -- -- -- -- $87.39M -- -- -- $217.9M
Investing Cash Flow -$7.80M -$27.48M $15.54M -$23.28M $21.56M $44.77M $3.25M -$30.19M $84.83M -$42.56M
Common Stock Issued -- $16.41M -- -- $31.99M -- -- $64.88M $711K $71.35M
Financing Cash Flow $36.43M $49.03M $7.86M $0 $62.16M $1.31M $24K $65.27M $1.44M $71.36M
Net Change in Cash -$4.16M -$3.88M -$539K -$50.30M $47.00M $11.30M -$34.04M -$5.91M $40.06M $945K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$20.34M -$17.96M -$13.69M -$12.32M -$10.16M -$8.00M $15.19M -$12.11M
Depreciation & Amortization $95K $34K $29K $26K $28K $29K $22K $20K
Stock-Based Compensation $2.83M $2.61M $2.65M $1.57M $1.25M $1.26M $1.25M $813K
Change in Payables $1.60M -$650K $2.21M $517K -$1.16M $1.83M -$1.27M $709K
Operating Cash Flow -$12.21M -$15.40M -$10.37M -$9.19M -$9.57M -$5.78M -$8.26M -$8.46M
Capital Expenditure -$66K -$582K -$91K -$25K $0 -$113K -$36K --
Free Cash Flow -$12.28M -$15.98M -$10.46M -$9.22M -$9.57M -$5.89M -$8.30M --
Purchases of Investments -$30.38M -$47.74M -$161.7M -$13.42M -$31.15M -$39.48M -$7.71M -$20.36M
Investing Cash Flow $7.52M -$5.96M -$144.8M $10.88M -$2.62M -$20.30M $4.24M -$6.08M
Common Stock Issued $0 $0 $189.4M -- -- -- -- --
Financing Cash Flow $805K $166K $190.7M $20K $360K $35.77M $279K --
Net Change in Cash -$3.89M -$21.20M $35.53M $1.71M -$11.82M $9.69M -$3.74M $4.06M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -25.0% -191.3% -69.9% -73.6% -44.5% -8.3% -65.6% -42.5% -65.6% -27.4%
Return on Assets (ROA) -21.5% -90.4% -59.3% -60.5% -39.5% -7.0% -55.8% -39.7% -58.7% -26.0%
Current Ratio 6.21x 1.54x 4.07x 4.06x 7.36x 3.73x 7.76x 16.45x 10.17x 22.89x
Quick Ratio 6.06x 1.47x 3.95x 3.99x 7.17x 3.65x 7.63x 16.31x 10.05x 22.70x
Debt to Equity 0.02x 0.03x 0.04x 0.05x 0.04x 0.03x 0.04x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -30.9% -24.0% -18.4% -25.0% -21.0% -56.3% -83.9% -191.3%
Return on Assets (ROA) -28.7% -22.6% -17.4% -21.5% -18.7% -50.5% -69.7% -90.4%
Current Ratio 13.38x 16.16x 19.81x 6.21x 8.29x 8.91x 4.90x 1.54x
Quick Ratio 13.16x 15.74x 19.55x 6.06x 8.14x 8.76x 4.77x 1.47x
Debt to Equity 0.00x 0.00x 0.00x 0.02x 0.01x 0.01x 0.02x 0.03x
Net Income Growth (YoY) -- -- -190.1% -- -- -- -- --
EPS Growth (YoY) -- -- -171.4% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001626971) · from December 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal